Esomeprazole News and Research

RSS
Esomeprazole is a drug that blocks acid from being made in the stomach. It is used to treat acid reflux disease and to prevent certain types of gastrointestinal ulcers. Esomeprazole magnesium is being studied in the prevention of esophageal cancer and in the treatment of other conditions, including side effects of chemotherapy. It is a type of anti-ulcer agent. Also called esomeprazole and Nexium.
Study challenges link between proton pump inhibitors and kidney disease risk

Study challenges link between proton pump inhibitors and kidney disease risk

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

The efficacy of clarithromycin versus levofoxacin-based regimens for H.pylori treatment in naïve patients after the COVID-19 pandemic misuse of antibiotics

The efficacy of clarithromycin versus levofoxacin-based regimens for H.pylori treatment in naïve patients after the COVID-19 pandemic misuse of antibiotics

Common heart burn medication could lessen the effectiveness of lung cancer treatment

Common heart burn medication could lessen the effectiveness of lung cancer treatment

Researchers describe a simple, inexpensive way to measure drug dissolution

Researchers describe a simple, inexpensive way to measure drug dissolution

Small molecule drugs binding Mac1 domain of SARS-CoV-2

Small molecule drugs binding Mac1 domain of SARS-CoV-2

Study shows how long-term use of acid suppressants could increase risk of dementia

Study shows how long-term use of acid suppressants could increase risk of dementia

Acid reflux drugs may lead to increased risk of fractures in children

Acid reflux drugs may lead to increased risk of fractures in children

Gastroesophageal reflux disease may affect nearly a third of U.S. adults every week

Gastroesophageal reflux disease may affect nearly a third of U.S. adults every week

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

Common medications to treat heartburn linked to increased risks for kidney failure

Common medications to treat heartburn linked to increased risks for kidney failure

Esophageal cancer risk could be reduced by esomeprazole and low dose aspirin

Esophageal cancer risk could be reduced by esomeprazole and low dose aspirin

Study investigates use of drugs for the stomach and risk of major depressive disorder

Study investigates use of drugs for the stomach and risk of major depressive disorder

Proton pump inhibitors linked to increased death risk

Proton pump inhibitors linked to increased death risk

Chronic use of antacid drugs may speed up aging of blood vessels

Chronic use of antacid drugs may speed up aging of blood vessels

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.